Supporting Information
| Supporting Information File 1: Experimental procedures and spectral data | ||
| Format: PDF | Size: 172.3 KB | Download |
Cite the Following Article
Synthesis of a novel analogue of DPP-4 inhibitor Alogliptin: Introduction of a spirocyclic moiety on the piperidine ring
Arumugam Kodimuthali, Padala Lakshmi Prasunamba and Manojit Pal
Beilstein J. Org. Chem. 2010, 6, No. 71.
https://doi.org/10.3762/bjoc.6.71
How to Cite
Kodimuthali, A.; Prasunamba, P. L.; Pal, M. Beilstein J. Org. Chem. 2010, 6, No. 71. doi:10.3762/bjoc.6.71
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Pal, S.; Pal, M. Anti-diabetes Research in India: Contributions from Industrial Organizations. Drug Discovery and Drug Development; Springer Singapore, 2021; pp 179–212. doi:10.1007/978-981-15-8002-4_8
- Jha, V.; Bhadoriya, K. S. Synthesis, pharmacological evaluation and molecular docking studies of pyrimidinedione based DPP-4 inhibitors as antidiabetic agents. Journal of Molecular Structure 2018, 1158, 96–105. doi:10.1016/j.molstruc.2018.01.014
- Lu, Y.; Yang, D.; Li, Z.; Hang, T.; Song, M. Isolation and characterization of related substances in alogliptin benzoate by LC-QTOF mass spectrometric techniques. Journal of pharmaceutical and biomedical analysis 2016, 128, 253–263. doi:10.1016/j.jpba.2016.04.032
- Jammula, S.; Anna, V. R.; Khobare, S. R.; Kumar, U. K. S.; Prasad, B.; Pal, M. Dehydrative Annulation Strategy for the Construction of Octahydroindolizine Framework: A Diastereoselective Synthesis of (6R,8aS)-Octahydroindolizin-6-ol. Synthetic Communications 2015, 45, 2576–2582. doi:10.1080/00397911.2015.1093146
- Parsa, K. V. L.; Pal, M. Preclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview. Expert opinion on drug discovery 2011, 6, 855–869. doi:10.1517/17460441.2011.588695
